We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Hill-Rom TruSystem 3000 Table Boosts Surgical Solution Suite
Read MoreHide Full Article
Medical device major Hill-Rom Holdings, Inc. recently launched TruSystem 3000 Mobile Operating Table. The table has been designed to fulfill hospitals' need to equip operating rooms with quality medical devices at a reasonable cost. The new mobile operating table introduced under the Surgical Solutions segment is currently available in most countries of Europe, Latin America, the Middle East, Africa and Asia.
Meanwhile, we must take note that Hill-Rom recently posted its first-quarter fiscal 2017 report. The company’s Surgical Solutions segment revenues during the reported quarter inched up 1.1% (up 3.2% at CER) on robust sale of its surgical positioning products and increased traction of its Integrated Table Motion. Meanwhile, the latest addition of an affordable and flexible operating table enhances the Surgical Solutions portfolio further.
Management claims that the TruSystem 3000 Mobile Operating Table can be customized for different surgical procedures. The user interfaces are reliable in design, using easily recognizable icons, colors and symbols to guarantee simplicity, efficiency and safety. In addition, the backlit display of the remote control enhances ease of use and safety in low-light surgical environments. The table can bear weight up to 270 kg, which covers a broad variety of individual patient and surgical needs.
As per a Transparency Market Research report, the global surgical equipment market is estimated to grow at a CAGR of 4.2% by 2019. Hill-Rom is therefore making efforts to capture the untapped potential of this growing market. Before launching the TruSystem 3000 Mobile Operating Table, it announced the launch of Allen Advance Table Lateral System, a unique offering to complement its Allen Advance Table.
Share Price Performance
Hill-Rom outperformed the Zacks categorized Medical - Products industry in the last three months. In spite of a top-line underperformance in the just-reported fiscal first quarter, the share price rose 5.5% over the past three months, much better than the broader industry's gain of 0.1%.
We are also upbeat about the company’s top-and-bottom-line guidance for the second quarter of fiscal 2017, strong growth in U.S. and solid margins. Based on these catalysts, we expect Hill-Rom to maintain its bullish share price trend in the days ahead. We are also looking forward to its plan to acquire Mortara Instrument and management’s plan of product expansion under its growing surgical product portfolio.
Zacks Rank & Other Key Picks
Hill-Rom currently has a Zacks Rank #2 (Buy). Other favorably ranked medical stocks are Glaukos Corporation (GKOS - Free Report) , Cardiovascular Systems and Neogen Corp. (NEOG - Free Report) . Glaukos sports a Zacks Rank #1 (Strong Buy) while Cardiovascular Systems carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Glaukos gained over 100% in the last one year in comparison to the S&P 500’s gain of only 17.6%. The company has a stellar four-quarter average earnings surprise of over 100%.
Cardiovascular Systems surged over 100% in the last one year in comparison to the S&P 500. It has a four-quarter average earnings surprise of 67.8%.
Neogen gained 22.2% in the past one year, better than the S&P 500 mark. The stock has an impressive long-term earnings growth of 16.7% for the next five years compared to the industry average of 15.2%.
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Hill-Rom TruSystem 3000 Table Boosts Surgical Solution Suite
Medical device major Hill-Rom Holdings, Inc. recently launched TruSystem 3000 Mobile Operating Table. The table has been designed to fulfill hospitals' need to equip operating rooms with quality medical devices at a reasonable cost. The new mobile operating table introduced under the Surgical Solutions segment is currently available in most countries of Europe, Latin America, the Middle East, Africa and Asia.
Meanwhile, we must take note that Hill-Rom recently posted its first-quarter fiscal 2017 report. The company’s Surgical Solutions segment revenues during the reported quarter inched up 1.1% (up 3.2% at CER) on robust sale of its surgical positioning products and increased traction of its Integrated Table Motion. Meanwhile, the latest addition of an affordable and flexible operating table enhances the Surgical Solutions portfolio further.
Management claims that the TruSystem 3000 Mobile Operating Table can be customized for different surgical procedures. The user interfaces are reliable in design, using easily recognizable icons, colors and symbols to guarantee simplicity, efficiency and safety. In addition, the backlit display of the remote control enhances ease of use and safety in low-light surgical environments. The table can bear weight up to 270 kg, which covers a broad variety of individual patient and surgical needs.
Hill-Rom Holdings Inc Price
Hill-Rom Holdings Inc Price | Hill-Rom Holdings Inc Quote
As per a Transparency Market Research report, the global surgical equipment market is estimated to grow at a CAGR of 4.2% by 2019. Hill-Rom is therefore making efforts to capture the untapped potential of this growing market. Before launching the TruSystem 3000 Mobile Operating Table, it announced the launch of Allen Advance Table Lateral System, a unique offering to complement its Allen Advance Table.
Share Price Performance
Hill-Rom outperformed the Zacks categorized Medical - Products industry in the last three months. In spite of a top-line underperformance in the just-reported fiscal first quarter, the share price rose 5.5% over the past three months, much better than the broader industry's gain of 0.1%.
We are also upbeat about the company’s top-and-bottom-line guidance for the second quarter of fiscal 2017, strong growth in U.S. and solid margins. Based on these catalysts, we expect Hill-Rom to maintain its bullish share price trend in the days ahead. We are also looking forward to its plan to acquire Mortara Instrument and management’s plan of product expansion under its growing surgical product portfolio.
Zacks Rank & Other Key Picks
Hill-Rom currently has a Zacks Rank #2 (Buy). Other favorably ranked medical stocks are Glaukos Corporation (GKOS - Free Report) , Cardiovascular Systems and Neogen Corp. (NEOG - Free Report) . Glaukos sports a Zacks Rank #1 (Strong Buy) while Cardiovascular Systems carries a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
Glaukos gained over 100% in the last one year in comparison to the S&P 500’s gain of only 17.6%. The company has a stellar four-quarter average earnings surprise of over 100%.
Cardiovascular Systems surged over 100% in the last one year in comparison to the S&P 500. It has a four-quarter average earnings surprise of 67.8%.
Neogen gained 22.2% in the past one year, better than the S&P 500 mark. The stock has an impressive long-term earnings growth of 16.7% for the next five years compared to the industry average of 15.2%.
Zacks' Top 10 Stocks for 2017
In addition to the stocks discussed above, would you like to know about our 10 finest tickers for the entirety of 2017?
Who wouldn't? These 10 are painstakingly hand-picked from 4,400 companies covered by the Zacks Rank. They are our primary picks to buy and hold. Be among the very first to see them >>